Lilly Loses Neuroscience Chief To Johnson & Johnson
Eli Lilly & Co. continues to search for a new head of neurology research as its diagnostic drug Amyvid (florbetapir F 18 injection) nears its user fee goal date.
Eli Lilly & Co. continues to search for a new head of neurology research as its diagnostic drug Amyvid (florbetapir F 18 injection) nears its user fee goal date.